PUBLICATION

Phenotypic evaluation of constitutive GPCR/G-protein signaling in zebrafish embryos and larvae

Authors
Shibata, T., Kawakami, K., Kawana, H., Aoki, J., Inoue, A.
ID
ZDB-PUB-220308-20
Date
2022
Source
Biochemical and Biophysical Research Communications   602: 70-76 (Journal)
Registered Authors
Keywords
Constitutive activity, CysLT(2)R, G protein, GPCR, L129Q, Zebrafish
MeSH Terms
  • Animals
  • Carcinogenesis
  • GTP-Binding Protein alpha Subunits, Gq-G11*/metabolism
  • Larva/metabolism
  • Ligands
  • Phenotype
  • RNA, Messenger
  • Receptors, G-Protein-Coupled/genetics
  • Receptors, G-Protein-Coupled/metabolism
  • Zebrafish*/genetics
PubMed
35255436 Full text @ Biochem. Biophys. Res. Commun.
Abstract
Signal transduction initiation by G-protein-coupled receptors (GPCRs) normally begins upon extracellular ligand binding. Some oncogenic GPCR mutants are capable of inducing G-protein signaling without ligand stimulation, thus behaving as constitutively active receptors. Evaluation of disease-causing capacity of constitutively active mutations in animal models requires months of time-consuming experiments, which hampers research progress. Here, using zebrafish embryos transiently expressing with constitutively active mutations via mRNA microinjection, we describe G-protein-subtype-specific phenotypes that can be evaluated over several days. Exogenous expression of the cysteinyl leukotriene receptor type II (CysLT2R) with an oncogenic L1293.43Q mutation by mRNA injection into a fertilized embryo induced developmental arrest during epiboly and eventual embryonic lethality, which were suppressed by treatment with the Gq inhibitor, YM-254890. Embryos with a constitutively active Gαq mutant exhibited an analogous phenotype. Interestingly, expression of constitutively active Gαs, Gαi, and Gα13 mutants induced distinct phenotypes. These phenotypes may thus serve as useful indicators for rapid in vivo evaluation of signaling activity of GPCR and G-protein mutants.
Genes / Markers
Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping